PharmaEngine (4162) — Free Cash Flow Generation Index
PharmaEngine (4162) has a Free Cash Flow Generation Index of 1.00x as of September 2025. Free cash flow of NT$52.90 Million represents 1% of operating cash flow (NT$53.01 Million). Explore 4162 capital expenditure intensity to see what proportion of operating cash flow is directed to capital expenditures.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
PharmaEngine Free Cash Flow Generation Index (2011–2024)
Historical FCF Generation Index trend for PharmaEngine across 12 annual periods. For the full cash flow conversion analysis, see PharmaEngine operating cash flow efficiency.
Annual Free Cash Flow Generation for PharmaEngine (2011–2024)
Year-by-year Free Cash Flow Generation Index for PharmaEngine. Check cash flow reinvestment rate of PharmaEngine to assess the company's total reinvestment commitment from operating cash flow.
| Year | FCG Index | Free Cash Flow (TWD) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2024 | 1.00x | NT$455.32 Million | NT$456.73 Million | NT$1.42 Million | ▲ +0.1% |
| 2023 | 1.00x | NT$256.01 Million | NT$256.97 Million | NT$958.00K | ▲ +1.6% |
| 2022 | 0.98x | NT$198.07 Million | NT$202.01 Million | NT$3.94 Million | ▼ -1.9% |
| 2021 | 1.00x | NT$929.44 Million | NT$929.67 Million | NT$229.00K | ▲ +0.9% |
| 2020 | 0.99x | NT$64.16 Million | NT$64.77 Million | NT$608.00K | ▲ +0.4% |
| 2019 | 0.99x | NT$15.87 Million | NT$16.08 Million | NT$208.00K | ▼ -1.2% |
| 2018 | 1.00x | NT$744.72 Million | NT$745.23 Million | NT$510.00K | ▲ +0.1% |
| 2016 | 1.00x | NT$869.24 Million | NT$870.38 Million | NT$1.15 Million | ▲ +2.6% |
| 2015 | 0.97x | NT$436.19 Million | NT$447.99 Million | NT$11.80 Million | ▼ -2.6% |
| 2014 | 1.00x | NT$130.99 Million | NT$131.09 Million | NT$95.00K | ▲ +0.0% |
| 2012 | 1.00x | NT$68.56 Million | NT$68.64 Million | NT$83.00K | ▲ +0.2% |
| 2011 | 1.00x | NT$274.68 Million | NT$275.49 Million | NT$806.00K | — |